Basic & Clinical Medicine ›› 2016, Vol. 36 ›› Issue (11): 1582-1585.

Previous Articles     Next Articles

Pharmacological mechanism and clinical progress of puerarin in the treatment of type 2 diabetes

1,   

  • Received:2015-11-30 Revised:2016-03-27 Online:2016-11-05 Published:2016-10-24

Abstract: Puerarin has been shown to act as a hypoglycemic, lipid-lowering, improvement of insulin resistance, anti-inflammatory, anti-oxidative stress compound in recent years. Puerarin may partly ameliorated the development of diabetes and its complications such as retina, kidney, cardiovascular and neurological diseases, and thus can be an effective approach for the intervention in clinical diabetes.

Key words: puerarin, type 2 diabetes

CLC Number: